- Home
- YORW vs AMLX Comparison
YORW vs AMLX Comparison
Compare YORW & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- AMLX
- Stock Information
- Founded
- YORW 1816
- AMLX 2014
- Country
- YORW United States
- AMLX United States
- Employees
- YORW N/A
- AMLX N/A
- Industry
- YORW Water Supply
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- YORW Utilities
- AMLX Health Care
- Exchange
- YORW Nasdaq
- AMLX Nasdaq
- Market Cap
- YORW 546.3M
- AMLX 481.9M
- IPO Year
- YORW N/A
- AMLX 2022
- Fundamental
- Price
- YORW $35.47
- AMLX $5.19
- Analyst Decision
- YORW
- AMLX Buy
- Analyst Count
- YORW 0
- AMLX 7
- Target Price
- YORW N/A
- AMLX $7.60
- AVG Volume (30 Days)
- YORW 38.9K
- AMLX 1.7M
- Earning Date
- YORW 11-07-2024
- AMLX 11-07-2024
- Dividend Yield
- YORW 2.38%
- AMLX N/A
- EPS Growth
- YORW N/A
- AMLX N/A
- EPS
- YORW 1.48
- AMLX N/A
- Revenue
- YORW $74,189,000.00
- AMLX $196,485,000.00
- Revenue This Year
- YORW $7.70
- AMLX N/A
- Revenue Next Year
- YORW $5.33
- AMLX $149.49
- P/E Ratio
- YORW $23.99
- AMLX N/A
- Revenue Growth
- YORW 9.03
- AMLX N/A
- 52 Week Low
- YORW $33.32
- AMLX $1.58
- 52 Week High
- YORW $41.96
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- YORW 42.09
- AMLX 50.53
- Support Level
- YORW $35.36
- AMLX $5.09
- Resistance Level
- YORW $36.06
- AMLX $5.88
- Average True Range (ATR)
- YORW 0.67
- AMLX 0.61
- MACD
- YORW -0.06
- AMLX -0.20
- Stochastic Oscillator
- YORW 13.43
- AMLX 22.96
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and two wastewater treatment systems. The company operates within its franchised territory, which covers more than 54 municipalities within York County, Pennsylvania.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.